MediPharm Labs Corp
Research MediPharm Labs Corp (MLZ) on Bullrun: market cap EUR 16.99M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMLZ
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 16.99M
- Financial periodQ4 2025
- RevenueEUR 11.06M
- Net income-EUR 1.97M
- Free cash flowEUR 435.00K
- Gross margin35.2%
Valuation Snapshot
latest market cap is EUR 16.99M.
About MediPharm Labs Corp
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products.
Frequently asked questions
What is MediPharm Labs Corp's market cap?
MediPharm Labs Corp's market capitalization is EUR 16.99M.
What does MediPharm Labs Corp do?
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.